0001127602-22-007174.txt : 20220228 0001127602-22-007174.hdr.sgml : 20220228 20220228191606 ACCESSION NUMBER: 0001127602-22-007174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAIN ALAN J CENTRAL INDEX KEY: 0001227372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 22692893 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-28 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001227372 MAIN ALAN J 2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR THE WOODLANDS TX 77381 1 EVP, Innov & Chem Sciences Common Stock 2022-02-28 4 M 0 22373 A 163068 D Common Stock 2022-02-28 4 M 0 23300 A 186368 D Common Stock 2022-02-28 4 M 0 8977 A 195345 D Common Stock 2022-02-28 4 F 0 19756 2.85 D 175589 D Restricted Stock Units 2022-02-28 4 M 0 22373 D Common Stock 22373 0 D Restricted Stock Units 2022-02-28 4 M 0 23300 D Common Stock 23300 23300 D Restricted Stock Units 2022-02-28 4 M 0 8977 D Common Stock 8977 17953 D Each restricted stock unit represents a contingent right to receive one share of common stock. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. /s/ Alan J. Main, Ph.D. 2022-02-28